Alkem Laboratories Limited
ALKEM
Rang in aandelen
#2813
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Aandeelprijs
$55.19
Marktkapitalisatie
$6.60B
Verandering (1 dag)
-0.06%
Verandering (1 jaar)
-12.43%
Land
IN
Handel Alkem Laboratories Limited (ALKEM)
Categorie
Healthcare
Winst voor Alkem Laboratories Limited (ALKEM)
Winst in Jun 2026 TTM: $316.88M
Volgens de meest recente financiële verslagen van Alkem Laboratories Limited bedraagt de huidige winst van het bedrijf $316.88M. In 2024 behaalde het bedrijf een winst van $242.63M, een stijging ten opzichte van de winst van 2023, die $158.77M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Alkem Laboratories Limited van 2010 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $316.88M | 7.25% |
| 2025 | $295.47M | 21.78% |
| 2024 | $242.63M | 52.82% |
| 2023 | $158.77M | -34.65% |
| 2022 | $242.96M | -3.45% |
| 2021 | $251.64M | 50.48% |
| 2020 | $167.23M | 21.64% |
| 2019 | $137.48M | -3.33% |
| 2018 | $142.22M | -4.39% |
| 2017 | $148.75M | 6.15% |
| 2016 | $140.14M | 93.97% |
| 2015 | $72.25M | -3.44% |
| 2014 | $74.83M | -20.27% |
| 2013 | $93.85M | 4.73% |
| 2012 | $89.61M | 12.42% |
| 2011 | $79.71M | 46.07% |
| 2010 | $54.57M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 456.85% |
IN
|
